Kerry Corning initiates phase 1 trial for narcoleptic drug

Mar 14, 2018

XW Laboratories Inc. has launched the first human body for the new narcoleptic drug XW10172 in Australia Phase I clinical trials to assess its safety, human tolerance, and pharmacokinetic properties. XW10172 is the first compound that Kerry Corning has independently ...

Read More

Australian scientists to develop blood test for lung cancer

Mar 14, 2018

The biomarker is expected to aid in predicting patients who would potentially respond to anti-PD-1 and anti-CTLA-4 immunotherapies. A team of scientists from the Walter and Eliza Hall Institute of Medical Research in Australia have discovered a unique molecular signature ...

Read More

Merck snaps up Australian firm Viralytics for $394M

Feb 27, 2018

The deal gives Merck access to Viralytics’s investigational oncolytic immunotherapy Cavatak, that has been shown to preferentially infect and kill cancer cells.   In  a bid to further broaden its immune-oncology portfolio, Merck has recently acquired Australian firm Viralytics for ...

Read More